Thermo Fisher Scientific Inc. (NYSE:TMO) reported better-than-expected financial results for the second quarter, with both profit and revenue surpassing analysts’ estimates.
The scientific instruments and healthcare giant posted adjusted earnings per share of $5.36, exceeding the consensus forecast of $5.23. Revenue came in at $10.85 billion, marking a 3% increase year-over-year and outpacing the expected $10.68 billion.
Investors reacted positively to the results, sending Thermo Fisher shares up 2.3% in premarket trading as of 06:06 ET Wednesday.
“Our exceptional team continues to execute at a high level, enabling customer success while navigating the macroenvironment,” said Marc N. Casper, chairman, president, and CEO of Thermo Fisher Scientific.
The company reported adjusted operating income of $2.38 billion, slightly above the $2.35 billion recorded during the same quarter last year.
However, the adjusted operating margin edged down to 21.9%, compared to 22.3% in Q2 of the prior year.
Thermo Fisher Scientific stock price
This content is for informational purposes only and does not constitute financial, investment, or other professional advice. It should not be considered a recommendation to buy or sell any securities or financial instruments. All investments involve risk, including the potential loss of principal. Past performance is not indicative of future results. You should conduct your own research and consult with a qualified financial advisor before making any investment decisions.